Katrina J. Church - Apr 10, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Apr 10, 2024
Transactions value $
$0
Form type
4
Date filed
4/12/2024, 04:53 PM
Previous filing
Mar 22, 2024
Next filing
Apr 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +4.3K +30.57% 18.4K Apr 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -4.3K -25% $0.00 12.9K Apr 10, 2024 Class A Common Stock 4.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.